Back
Maze Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14
MAZE
Maze Therapeutics, Inc.
Last Price:
$44.27
Seasonality Move:
-26.03%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and MAZE is experiencing slight selling pressure.
Maze Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.24 | Sell |
| 20-day SMA: | 45.77 | Sell |
| 50-day SMA: | 42.77 | Buy |
| 200-day SMA: | 26 | Buy |
| 8-day EMA: | 45.62 | Sell |
| 20-day EMA: | 45.27 | Sell |
| 50-day EMA: | 42.5 | Buy |
| 200-day EMA: | 28.65 | Buy |
Maze Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.88 | Buy |
| Relative Strength Index (14 RSI): | 48.48 | Sell |
| Chaikin Money Flow: | -23021 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.13 - 47.29) | Sell |
| Bollinger Bands (100): | (30.84 - 43.96) | Buy |
Maze Therapeutics, Inc. Technical Analysis
| Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Maze Therapeutics, Inc. Stock
Is Maze Therapeutics, Inc. Stock a Buy?
-
Maze Therapeutics, Inc. share price is 44.22 while MAZE 8-day simple moving average is 46.24, which is a Sell signal.
-
The stock price of MAZE is 44.22 while Maze Therapeutics, Inc. 20-day SMA is 45.77, which makes it a Sell.
-
Maze Therapeutics, Inc. 50-day simple moving average is 42.77 while MAZE share price is 44.22, making it a Buy technically.
-
MAZE stock price is 44.22 and Maze Therapeutics, Inc. 200-day simple moving average is 26.00, creating a Buy signal.
MAZE Technical Analysis vs Fundamental Analysis
Sell
14
Maze Therapeutics, Inc. (MAZE)
is a Sell
Is Maze Therapeutics, Inc. a Buy or a Sell?
-
Maze Therapeutics, Inc. stock is rated a SellThe current Maze Therapeutics, Inc. [MAZE] share price is $44.22. The Score for MAZE is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
Maze Therapeutics, Inc. Stock Info
Market Cap:
2.1B
Price in USD:
44.22
Share Volume:
267.6K
Maze Therapeutics, Inc. 52-Week Range
52-Week High:
49.25
52-Week Low:
6.71
Sell
14
Maze Therapeutics, Inc. (MAZE)
is a Sell
Maze Therapeutics, Inc. Share Price Forecast
-
What is the Maze Therapeutics, Inc. stock price today?The Maze Therapeutics, Inc. stock price is 44.22 USD today.
-
Will MAZE stock go up or go down?Maze Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Maze Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Maze Therapeutics, Inc. is overvalued.
Is Maze Therapeutics, Inc. Stock a Buy?
-
Maze Therapeutics, Inc. share price is 44.22 while MAZE 8-day exponential moving average is 45.62, which is a Sell signal.
-
The stock price of MAZE is 44.22 while Maze Therapeutics, Inc. 20-day EMA is 45.27, which makes it a Sell.
-
Maze Therapeutics, Inc. 50-day exponential moving average is 42.50 while MAZE share price is 44.22, making it a Buy technically.
-
MAZE stock price is 44.22 and Maze Therapeutics, Inc. 200-day simple moving average is 28.65, creating a Buy signal.
Fundamental Analysis of Maze Therapeutics, Inc.
Is Maze Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.24 per share.
Technical Analysis of Maze Therapeutics, Inc.
Should I short Maze Therapeutics, Inc. stock?
-
MAZE Moving Average Covergence Divergence (MACD) indicator is 0.88, suggesting Maze Therapeutics, Inc. is a Buy
-
Maze Therapeutics, Inc. Relative Strength Index (RSI) is 48.48, which suggest Maze Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Maze Therapeutics, Inc. is (43.13 - 47.29), which suggest Maze Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Maze Therapeutics, Inc. is (30.84 - 43.96), which suggest Maze Therapeutics, Inc. is a Buy
* Maze Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.